Fatemeh Rezaei-Tazangi | Neuroscience Discoveries | Best Research Article Award

Published on by Scientist Day

Dr. Fatemeh Rezaei-Tazangi | Neuroscience Discoveries | Best Research Article Award

Fasa University of Medical Sciences | Iran

Dr. Fatemeh Rezaei-Tazangi, affiliated with Fasa University of Medical Sciences, Iran, is a distinguished researcher in the fields of stem cells, reproductive medicine, cancer biology, and herbal therapeutics. She holds a Ph.D. in Anatomical Sciences from Ahvaz Jundishapur University of Medical Sciences, building on her earlier studies in midwifery and anatomical sciences at Shiraz University of Medical Sciences. Her scholarly contributions are widely recognized, with 59 published documents indexed in Scopus, cited by 568 publications, amounting to 630 citations and an h-index of 13, reflecting the strong impact of her research. Dr. Rezaei-Tazangi’s investigations bridge experimental and translational science, with a special focus on mesenchymal stem cells, oxidative stress, fertility preservation, and the therapeutic promise of natural compounds and nano-based drug formulations. She has provided valuable insights into mechanisms such as ferroptosis, autophagy, epithelial-mesenchymal transition, and stem cell-derived secretomes in relation to cancer and regenerative medicine. Her collaborative research record includes work with over 260 co-authors, highlighting her active engagement with the global scientific community. By combining advanced cellular biology with herbal and nanotechnology-based approaches, she contributes to the development of innovative strategies for reproductive health and oncology. With a growing research impact and a diverse body of work, Dr. Rezaei-Tazangi is an emerging leader in biomedical sciences, committed to advancing healthcare solutions through interdisciplinary and impactful research.

Profile: Scopus | Google Scholar | Orcid

Featured Publications

“Receptor tyrosine kinase inhibitors in cancer”

“Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy”

“Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance”

“The emerging role of regulatory cell-based therapy in autoimmune disease”

“Nano-scale delivery systems for siRNA delivery in cancer therapy: New era of gene therapy empowered by nanotechnology”

“Taurine effects on Bisphenol A-induced oxidative stress in the mouse testicular mitochondria and sperm motility”

“Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response”

“The therapeutic potential of common herbal and nano-based herbal formulations against ovarian cancer: New insight into the current evidence”

“Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer”

“Quercetin and Osteoarthritis: A Mechanistic Review on the Present Documents”

“The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma”

“A review of methods for preserving male fertility”

“Can mesenchymal stem cells derived from adipose tissue and their conditioned medium improve ovarian functions? A mini-review”

“Effects of Wharton’s jelly mesenchymal stem cells-derived secretome on colon carcinoma HT-29 cells”

Tao Lu | Neuroscience Discoveries | Women Researcher Award

Published on by Scientist Day

Dr. Tao Lu | Neuroscience Discoveries | Women Researcher Award

Dr. Tao Lu | Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, China

Dr. Tao Lu has actively collaborated with renowned experts in medical imaging, notably working with Dr. Yì Xiáng J. Wáng from The Chinese University of Hong Kong on the development of Diffusion-Derived Vessel Density (DDVD), a novel MRI biomarker. This international collaboration highlights Dr. Lu’s commitment to advancing non-invasive imaging techniques and fostering global research partnerships in placental and fetal MRI.

Academic Profile 

Scopus

Education

Dr. Tao Lu holds a Doctorate in Medical Imaging, demonstrating a strong academic foundation in advanced diagnostic imaging and radiological sciences. Her educational journey has been firmly rooted in both clinical medicine and imaging research, equipping her with the expertise required to bridge clinical practice and technological innovation. This robust educational background underpins her work in placental and fetal MRI, enabling her to contribute meaningfully to both academic research and healthcare service delivery.

Experience

Dr. Tao Lu currently serves as an Associate Chief Physician at Sichuan Provincial People’s Hospital and as a Professor and Master Instructor at the University of Electronic Science and Technology of China. Her dual appointment reflects a strong blend of clinical excellence and academic leadership. In her clinical role, she manages complex imaging diagnostics and patient care, particularly in obstetric imaging. As a faculty member, she mentors postgraduate students and leads research initiatives that explore advanced MRI techniques. With years of experience in high-level healthcare settings and academic institutions, Dr. Lu has established herself as a key figure in the field of radiology and medical imaging.

Research Interests

Dr. Lu’s primary research interests lie in the application of advanced MRI techniques to obstetrics, particularly focusing on fetal MRI and placental MRI. She has conducted extensive research on placenta accreta spectrum (PAS) disorders using innovative diffusion-weighted imaging (DWI) and intravoxel incoherent motion (IVIM) models. Her work aims to improve the prenatal evaluation of placental perfusion and fetal brain development, with the goal of enabling earlier and more accurate clinical decision-making. By exploring quantitative imaging biomarkers and collaborating on novel MRI methodologies, she continues to push the boundaries of diagnostic capabilities in maternal-fetal medicine.

Awards

While specific awards are not explicitly listed, Dr. Tao Lu’s research achievements and professional roles reflect significant recognition in the field of radiology. She has published 55 articles in reputable indexed journals (SCI, Scopus), demonstrating her contribution to academic literature. Additionally, her involvement as a reviewer for international journals such as Insights into Imaging, Journal of MRI, MRI and Clinical Imaging, and Medicine Advances further underscores her expertise and standing in the academic community. Her selection as a collaborator by prestigious institutions such as The Chinese University of Hong Kong signifies her recognition on an international level, both as a researcher and clinical expert.

Publications

The relevance of placenta MRI diffusion-derived vessels density and morphological features in diagnosing placenta accreta spectrum – BMC Medical Imaging  (2025)

SMARCA4-deficient non-small cell lung cancer with metastasis to the sigmoid colon: a case report – World Journal of Surgical Oncology  (2025)

SRPL-SFDA: Sam-Guided Reliable Pseudo-Labels For Source-Free Domain Adaptation in medical image segmentation – Neurocomputing  (2025)

Diagnosing placenta accreta spectrum in different placental locations using a combination of magnetic resonance imaging (MRI) features and diffusion-weighted MRI parameters – Quantitative Imaging in Medicine and Surgery  (2025)

Pancreatic liposarcoma: A case report – Oncology Letters This link is disabled (2025)

Conclusion

Dr. Tao Lu stands out as a dedicated clinician-scientist whose work bridges the gap between clinical radiology and academic research. With a strong educational foundation, extensive clinical and teaching experience, and focused research in fetal and placental MRI, she contributes meaningfully to the advancement of maternal-fetal healthcare. Her collaborations with leading international experts and her role in high-impact publications further highlight her commitment to scientific excellence and innovation. As a researcher, educator, and medical professional, Dr. Lu continues to impact the field through her dedication to improving diagnostic accuracy and patient outcomes in perinatal imaging.